The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: Results from the nurses' health study

Cancer

Volumn 107, Issue 6, 2006, Pages 1240-1247

  Collins, Laura G ^a,e   Baer, Heather J ^b,c   Tamimi, Rulla M ^b,c   Connolly, James L ^a   Colditz, Graham A ^b,d   Schnitt, Stuart J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD CENTER FOR CANCER PREVENTION   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atypical hyperplasia; Benign breast disease; Breast cancer; Family history

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ALCOHOL DRINKING; BIOPSY; BODY MASS INDEX; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERPLASIA; LOGISTIC MODELS; MIDDLE AGED; NURSES; ODDS RATIO; PARITY; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33749016481     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22136     Document Type: Article

References (21)

1. Kodlin D, Winger EE, Morgenstern NL, Chen U. Chronic mastopathy and breast cancer. A follow-up study. Cancer. 1977;39:2603-2607.
2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-151.
3. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol. 1988;128:467-477.
4. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65:518-529.
5. Palli D, Rosselli del Turco M, Simoncini R, Bianchi S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer. 1991;47:703-706.
6. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941-944.
7. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol. 1992;135:619-631.
8. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer. 1992;69:1408-1414.
9. Dupont WD, Pari FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258-1265.
10. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer. 1993;71:3896-3907.
11. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of tabular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997;6:297-301.
12. Shaaban AM, Sloane JP, West CR, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002;26:421-430.
13. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229-237.
14. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053-1055.
15. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
16. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol. 1989;20:723-725.
17. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol. 1987;125:769-779.
18. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations [see comments]. N Engl J Med. 1998;338:1089-1096.
19. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
20. Colditz GA. The Nurses' Health Study: findings during 10 years of follow-up of a cohort of U.S. women. Curr Probl Obstet Gynecol Fertil. 1990;13:129-174.
21. Claus EB, Schildkraut J, Iversen ES Jr., Berry D, Parmigiani G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst. 1998;90:1824-1829.